We are live on
!
Find out more
SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
SNNA
Delisted
SNNA was delisted on the 16th of December, 2019.
52 hedge funds and large institutions have $184M invested in Sienna Biopharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
238% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 8
180% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 5
21% more funds holding
Funds holding: 43 → 52 (+9)
19% more capital invested
Capital invested by funds: $154M → $184M (+$30M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
52
Holders Change
+9
Holders Change %
+20.93%
% of All Funds
1.19%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
27
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$7.15M |
| 2 |
WCM
Wildcat Capital Management
New York
|
+$5.17M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.16M |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.81M |
| 5 |
Morgan Stanley
New York
|
+$2.74M |
